Replies to post #217111 on Biotech Values

[DewDiligence]

...according to GSK's ViiV the HIV total market is (sadly enough) expanding ~13% a year!

No need to be sad—the increasing addressable market for HIV drugs stems not from an increasing number of HIV-infected patients, but rather from increasing use of HIV regimens for prophylaxis.